The stars of Europe's equity market The stars of Europe's equity market The stars of Europe's equity market

The stars of Europe's equity market

Equities 5 minutes to read
Peter Garnry

Head of Saxo Strats

Summary:  European equities have been the key story in equity markets since early 2022 when the interest rate shock started and inflation turned out to be higher for longer. Not only are European equities outperforming but they are also much more attractive on valuation priced at a P/E ratio of 13.2x compared to 18.5x for US equities. Earnings estimates have also been rising faster this year in Europe compared to the US and this is despite of all the hype about AI. In this equity note we also highlight which 20 European stocks that have contributed most to the outperformance this year.


Key points in this equity note:

  • European equities continue to outperform US equities on top of still being much cheaper on P/E and dividend yield.
  • 12-month earnings estimates on European equities are outpacing US earnings estimates this year.
  • Europe’s stars in the equity market this year have been stocks such as LVMH, Novo Nordisk, and ASML.

European equities continue to shine over US equities

European equities are up 14% this year compared to 8.5% for US equities. If it had not been for the AI hype the numbers would have been even more in favour of European equities. If compare the price change this year to the actual change in underlying earnings and even more importantly the expected earnings then the US equity market has gotten even more expensive relative to European equities. STOXX 600 is currently priced at a forward P/E ratio of 13.2x and dividend yield of 3.5% compared to 18.5x and 1.7% respectively. The risk-reward ratio is clearly in favour of European equities and many US investors are looking to diversify their US exposure with more weight to Europe and Japan. For more perspective on Japanese equities read our recent equity note Will the sun rise over Japanese equities?

It is clear by now that in the age of inflation, European equities have just been better. Since the Covid vaccines were announced unleashing the comeback of the physical world and inflation, European equities have returned 39% compared to 32% for US equities. Since the peak in equities in late 2021, US equities have declined 11% while European equities have only lost 3%. With the US debt ceiling debate continuing and likely leading to a compromise which will include a reducing in the current US deficit then 2023/24 could become a period of lower government growth impulse in the US compared to a bigger impulse in Europe. In other words, European equities offer a better earnings outlook on top of a much lower starting point in terms of valuation. What is not to like?

US vs European equities | Source: Bloomberg

Earnings estimate upgrades highlight Europe’s momentum

It is not only in terms of performance that Europe is shining these days. When we look at 12-month earnings estimates then analysts have been consistently more optimistic about European earnings. The 12-month earnings estimate on STOXX 600 is up 1.7% this year while the S&P 500 earnings estimate is down 0.1% this year. One of the underlying forces is the demand on the physical world is outstripping demand on the digital world as the fragmentation of global supply chains is driving enormous amount of investments in the US and Europe. But what is more impressive about the performance by European companies is that it is done with a less fiscal impulse compared to the US where the fiscal deficit is around 7% of GDP while Europe is closer to 3.5%. The war in Ukraine has accelerated two powerful forces in Europe, 1) the green transformation which is driving the biggest electrification the world has ever seen, and 2) a doubling of military spending which will cause positive second order effects into Europe’s industry.

The European equity stars in 2023

While the US equity market is driven by the technology and health care sector, the European equity market is more diversified across consumer sectors, health care, financials, and energy. The table below shows the 20 European stocks that have contributed the most to this year’s performance. Out of the 14% total return this year in the STOXX 600 Index, 5.75%-point of that performance have come from 20 stocks which we call the stars of Europe this year.

Three of these companies are within the roaring luxury theme which we have written extensively on during the year and recent as last week in our equity note Luxury stocks do not care about China’s old economy. Luxury stocks led by the French luxury giant LVMH have been the preferred way to express a positive view on the Chinese reopening. Outside luxury stocks, there are three health care stocks (Novo Nordisk, Novartis, and AstraZeneca) that have helped pull the index higher this year. Health care stocks have incredibly high quality and defensive characteristics that are in high demand amid the uncertainty over the economy and inflation. The procyclical boom in infrastructure, green transformation, and the de-risking of supply chains have benefitted industrial and semiconductor companies such as ASML, Siemens, and Schneider Electric; read our equity note from yesterday on the booming demand for electric grid infrastructure in Europe.

On the top 20 list we also find European banks such as HSBC and UniCredit. While there was a brief banking crisis due to the failure of Silicon Valley Bank it has failed to materialise into anything here in Europe except for the merger between UBS and Credit Suisse. European banks have been a positive story this year with expanding net interest income and lower than expected loan loss provisions. US banks have underperformed European banks by a wide margin the past year as explained in our recent equity note Equity update: US banks, European earnings, and Apple earnings.

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)
Full disclaimer (https://www.home.saxo/legal/saxoselect-disclaimer/disclaimer)

Saxo Bank (Schweiz) AG
The Circle 38
CH-8058
Zürich-Flughafen
Switzerland

Contact Saxo

Select region

Switzerland
Switzerland

All trading carries risk. Losses can exceed deposits on margin products. You should consider whether you understand how our products work and whether you can afford to take the high risk of losing your money. To help you understand the risks involved we have put together a general Risk Warning series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. The KIDs can be accessed within the trading platform. Please note that the full prospectus can be obtained free of charge from Saxo Bank (Switzerland) ltd. or the issuer.

This website can be accessed worldwide however the information on the website is related to Saxo Bank (Switzerland) Ltd. All clients will directly engage with Saxo Bank (Switzerland) Ltd. and all client agreements will be entered into with Saxo Bank (Switzerland) Ltd. and thus governed by Swiss Law.

The content of this website represents marketing material and has not been notified or submitted to any supervisory authority.

If you contact Saxo Bank (Switzerland) Ltd. or visit this website, you acknowledge and agree that any data that you transmit to Saxo Bank (Switzerland) Ltd., either through this website, by telephone or by any other means of communication (e.g. e-mail), may be collected or recorded and transferred to other Saxo Bank Group companies or third parties in Switzerland or abroad and may be stored or otherwise processed by them or Saxo Bank (Switzerland) Ltd. You release Saxo Bank (Switzerland) Ltd. from its obligations under Swiss banking and securities dealer secrecies and, to the extent permitted by law, data protection laws as well as other laws and obligations to protect privacy. Saxo Bank (Switzerland) Ltd. has implemented appropriate technical and organizational measures to protect data from unauthorized processing and disclosure and applies appropriate safeguards to guarantee adequate protection of such data.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.